Complement activation products in tears of dry eye and meibomian gland dysfunction

Complement activation products in tears of dry eye and meibomian gland dysfunction

Abstract Sixty-seven patients (38 woman; median age, 69 years) were enrolled to assess complement activation products (CAPs) in tear fluid with/without dry eye (DE) and with/without meibomian gland dysfunction (MGD). Patients were divided into four groups based on the presence/absence of DE and MGD:...

Full description

Bibliographic Details
Main Authors: Hiroki Maehara, Koki Norikawa, Keiichiro Tanaka, Yutaka Kato, Akihito Kasai, Ryo Mukai, Tomoko Omori, Takeshi Machida, Hideharu Sekine, Tetsuju Sekiryu
Format: Article
Language:English
Published: Nature Portfolio 2024-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-46634-7

Similar Items

Similar Items